MFM Clinical Overview · 2026

Marginal Cord Insertion

Clinical Significance, Perinatal Implications & Management

ACOG · SMFM · Evidence-Based Practice

Definition & Prevalence

Umbilical cord insertion within 2 cm of the placental edge — distinct from central, eccentric, and velamentous insertions.

6–9%

of singleton pregnancies

↑ Risk

adverse perinatal outcomes (modest)

< VCI

severity vs. velamentous insertion

Fetal Growth Restriction

2.4–3.2×

adjusted odds ratio for SGA / low birth weight

FGR

independent risk factor (2025 retrospective study)

📋

ACOG Practice Bulletin: Marginal cord insertion listed among umbilical cord abnormalities associated with fetal growth restriction.

Preterm Birth & Placental Complications

3–4×

risk of preterm delivery <37 weeks (RR 3.2–4.0)

OR 2.6

placental abruption (n=634,741 Norwegian cohort)

OR 3.7

placenta previa (same population-based study)

Additional Perinatal Associations

Outcome	Effect Estimate	Risk Level
Pre-eclampsia	aOR ~2.9	Moderate
PROM	15.25% vs. 9.87% (normal)	Elevated
Emergency Cesarean	Independent risk factor	Significant
Perinatal Mortality	RR 1.53 (95% CI 0.62–3.78)	Not significant

Antenatal Surveillance

📡

Serial Growth Ultrasounds Every 3–4 weeks beginning in the third trimester when MCI is identified prenatally. Monitors for FGR and SGA.

❤️

Fetal Surveillance (NST / BPP) Initiated in the third trimester, particularly when concurrent risk factors are present (growth restriction, hypertension). No formal ACOG mandate for isolated MCI.

⚠️

Guideline Gap: No society-level guideline specifically addresses MCI management. ACOG CO #828 addresses VCI and SUA — not MCI specifically.

Delivery Planning

Mode of Delivery MCI alone is not an indication for cesarean delivery or early induction.

Delivery Setting Facility capable of emergency cesarean and neonatal resuscitation — given associations with abruption and emergency operative delivery.

Intrapartum Monitoring Continuous electronic fetal monitoring during labor is prudent given potential for cord compression or placental insufficiency.

Placental Pathology Submit placenta for histopathologic examination. Subchorionic vessel thrombus and other abnormalities are more prevalent with MCI.

MCI vs. Velamentous Cord Insertion

Marginal (MCI)

Cord within 2 cm of placental edge
Prevalence: 6–9% singletons
Modest increase in adverse outcomes
Perinatal mortality not significantly elevated
No vasa previa risk

Velamentous (VCI)

Cord inserts into membranes, not placenta
Substantially higher risk profile
Perinatal death OR 3.3 at term
SGA risk RR 2.19
Vasa previa risk — requires ACOG surveillance protocol

🔍

Clinical Action: Careful sonographic evaluation required to confirm MCI vs. VCI — the two can be difficult to differentiate on prenatal imaging.

Clinical Summary

🔬

Diagnose & Characterize Confirm MCI on ultrasound. Distinguish from velamentous insertion. Document insertion site.

📈

Surveil for Growth Serial growth ultrasounds every 3–4 weeks in the third trimester. Add fetal surveillance if concurrent risk factors present.

🏥

Plan Delivery Appropriately No routine early delivery or cesarean for isolated MCI. Deliver in a facility prepared for emergency operative delivery. Continuous EFM intrapartum.